Projects per year
Personal profile
Biography
Professor Rowe is the Foundation Professor of Neurology in the Faculty of Medicine and Health Sciences at Macquarie University; Chairman of Macquarie Neurology, and Consultant Neurologist at Macquarie University Hospital.
For ten years he was Chairman of the MND Research Institute of Australia, taking this funding body from minor influence to the major source of funding for MND research in Australia. He is the Principal Investigator on the Parkinson’s Progression Marker Initiative, re-sponsible for the only Australian site in this ground breaking collabo-rative research in PD. Together with Professor Kiernan and others, he founded the Australian Motor Neurone Disease Registry. For the last nine years he has been instrumental in the set up and im-plementation of the Faculty of Medicine and Health Sciences at Macquarie University.
Professor Rowe was awarded a Member of the Order of Australia in the 2012 Queen’s Birthday Honour List for services to Medicine and Neurology, particularly Motor Neurone Disease and Parkinson’s.
Professor Rowe is a member of the Australian and New Zealand Associ-ation of Neurologists; International Movement Disorder Society and a Fellow of the Royal Australasian College of Physicians.
He is a Chairman of Neurology at Macquarie University Hospital and the founder of Macquarie Neurolo-gy; an adult neurology practice that performs more than 10,000 patient episodes per year. Macquarie Neu-rology manages the care of more than 200 patients with MND, 600 patients with Parkinson’s and 100 patients with Multiple Sclerosis.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
MEND: A Phase 1 Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy Study of Oral Monepantel in patients with ALS/Motor Neuron Disease
Rowe, D., Gan, R., Bayeh, P. & Kalband, B.
1/07/22 → 30/06/27
Project: Research
-
REAL: A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients with Amyotrophic Lateral Sclerosis (ALS) REAL (Rho kinasE in ALs)
Rowe, D., Gan, R. & Bayeh, P.
13/05/22 → 31/05/27
Project: Research
-
A Multi-Centre Randomised Controlled Trial of Polysomnographic Titration of Non-Invasive Ventilation in Motor Neurone Disease
Berlowitz, D. J., Rowe, D., Howard, M., Piper, A., Graco, M., Braat, S., Singh , B., Sousa , T. V., Lannin , N., Gan, R., Bayeh, P., Pan, J., Barnes, K., Aiyappan, V., Curtin , D., Wu, P. & Birks, C.
1/02/21 → 31/12/25
Project: Research
-
A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, 60-Week, Phase II Clinical Trial of Three Re-Purposed Medications in Moderate Severity Parkinson’s Disease
Rowe, D. & Gan, R.
10/09/20 → 29/07/25
Project: Research
-
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
Tan, R. H., McCann, H., Shepherd, C. E., Pinkerton, M., Mazumder, S., Devenney, E. M., Adler, G. L., Rowe, D. B., Kril, J., Halliday, G. M. & Kiernan, M. C., Dec 2023, In: Acta Neuropathologica Communications. 11, 1, p. 1-12 12 p., 180.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure) -
Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis
Mazumder, S., McCann, H., D'Silva, S., Furlong, S., Shepherd, C. E., Kril, J. J., Halliday, G. M., Rowe, D. B., Kiernan, M. C. & Tan, R. H., 1 Mar 2023, In: Brain. 146, 3, p. e17-e19 3 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)9 Downloads (Pure) -
RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: considerations for biomarker discovery
Grima, N., Liu, S., Southwood, D., Henden, L., Smith, A., Lee, A., Rowe, D. B., D'Silva, S., Blair, I. P. & Williams, K. L., Dec 2023, In: Neuropathology and Applied Neurobiology. 49, 6, p. 1-16 16 p., e12943.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia
Henden, L., Fearnley, L. G., Grima, N., McCann, E. P., Dobson-Stone, C., Fitzpatrick, L., Friend, K., Hobson, L., Chan Moi Fat, S., Rowe, D. B., D'Silva, S., Kwok, J. B., Halliday, G. M., Kiernan, M. C., Mazumder, S., Timmins, H. C., Zoing, M., Pamphlett, R., Adams, L., Bahlo, M., & 2 others , 5 May 2023, In: Science Advances. 9, 18, p. 1-15 16 p., eade2044.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)16 Downloads (Pure) -
The importance of patient-centred drug development for amyotrophic lateral sclerosis
Kiernan, M. C., Halliday, G. M., Rowe, D. B. & Tan, R. H., Dec 2023, In: Neuropathology and Applied Neurobiology. 49, 6, p. 1 1 p., e12944.Research output: Contribution to journal › Letter › peer-review
Prizes
Activities
- 1 Invited talk
-
Rattling the Cage of Amyotrophic Lateral Sclerosis
Dominic Rowe (Speaker)
8 Nov 2019Activity: Talk or presentation › Invited talk